Lonza Group Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 6, 2012 46 Pages - SKU: ICDR6792627 |
| Synopsis ICD Research's Lonza Group Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Lonza Group Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Lonza Group Ltd. ICD Research's Lonza Group Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Lonza Group Ltd (Lonza) is one of leading suppliers of active pharmaceutical ingredients across the world. The company is engaged in the provision of peptides, large and small molecules, amino acids, niche bioproducts, value chemical, and biotech ingredients to various industries which include human and animal nutrition, life sciences, cosmetics, chemical, personal care, household, industrial and institutional cleaners, water treatment, and wood preservation. Lonza offers 3,500 products and services to more than 14,000 customers across America, Asia, Europe, Australia, and other countries. It operate in three divisions namely, Life Science ingredients, Custom Manufacturing and Bioscience. The company is headquartered in Basel, Switzerland. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

